Delek US (NYSE:DK - Get Free Report) had its price objective decreased by stock analysts at Wells Fargo & Company from $17.00 to $15.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an "underweight" rating on the oil and gas company's stock. Wells Fargo & Company's price target indicates a potential downside of 8.03% from the stock's current price.
Several other analysts have also recently issued reports on DK. JPMorgan Chase & Co. upped their price objective on Delek US from $21.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday, December 10th. Mizuho decreased their price objective on Delek US from $26.00 to $25.00 and set a "neutral" rating on the stock in a report on Monday, December 16th. Finally, Wolfe Research raised shares of Delek US from an "underperform" rating to a "peer perform" rating in a research note on Friday, January 3rd. Five research analysts have rated the stock with a sell rating and six have given a hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $20.90.
Get Our Latest Report on Delek US
Delek US Price Performance
Shares of NYSE:DK traded up $0.46 during trading on Wednesday, hitting $16.31. 2,454,631 shares of the company's stock were exchanged, compared to its average volume of 1,320,011. Delek US has a 52-week low of $15.02 and a 52-week high of $33.60. The business's 50-day simple moving average is $18.16 and its 200 day simple moving average is $18.54. The company has a debt-to-equity ratio of 3.18, a current ratio of 1.04 and a quick ratio of 0.67. The company has a market cap of $1.03 billion, a price-to-earnings ratio of -3.36 and a beta of 1.20.
Delek US (NYSE:DK - Get Free Report) last released its earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) EPS for the quarter, missing the consensus estimate of ($1.53) by ($1.01). The company had revenue of $2.37 billion during the quarter, compared to analysts' expectations of $2.58 billion. Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. Delek US's quarterly revenue was down 39.8% compared to the same quarter last year. During the same period last year, the firm posted ($1.46) EPS. As a group, equities analysts predict that Delek US will post -5.5 EPS for the current year.
Institutional Trading of Delek US
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DK. Sterling Capital Management LLC increased its stake in Delek US by 728.3% in the 4th quarter. Sterling Capital Management LLC now owns 1,491 shares of the oil and gas company's stock worth $28,000 after buying an additional 1,311 shares during the period. KBC Group NV lifted its holdings in shares of Delek US by 66.3% in the 4th quarter. KBC Group NV now owns 3,859 shares of the oil and gas company's stock worth $71,000 after buying an additional 1,538 shares during the period. Farther Finance Advisors LLC grew its position in shares of Delek US by 24.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 7,733 shares of the oil and gas company's stock worth $145,000 after buying an additional 1,508 shares in the last quarter. ARS Investment Partners LLC purchased a new position in shares of Delek US during the fourth quarter valued at $185,000. Finally, Capstone Investment Advisors LLC bought a new stake in shares of Delek US in the third quarter valued at about $193,000. 97.01% of the stock is owned by hedge funds and other institutional investors.
About Delek US
(
Get Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Read More

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.